Trulieve Expands Patient Access to Medical Cannabis with New Winter Haven Location
TALLAHASSEE, Fla., July 21, 2021 /PRNewswire/ – Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States, announced today the opening of a new Florida dispensary, the Company’s 96th nationwide.
The new 3,200 sq. ft. dispensary, located in Winter Haven, supports Trulieve’s goal of ensuring medical cannabis patients across Florida have safe, reliable access to the medications they rely on. The dispensary expands access throughout Central Florida, joining nearby locations in Lakeland and Sebring.
In honor of Trulieve’s 87th Florida dispensary, all patients — from those new to Trulieve to the dedicated Truliever community — will be eligible for a 25% in-store discount at the new dispensary on opening day.
ANNOUNCING: Trulieve Winter Haven Grand Opening
WHERE: 749 3rd Street SW, Winter Haven, FL 33880
WHEN: Thursday, July 22, 2021, at 9:00 a.m.
In stores and online, patients will find Florida’s largest selection of THC and CBD products in a variety of delivery methods, including edibles, smokable flower, concentrates, tinctures, topical creams, vaporizers, and more. Trulieve also offers home delivery statewide for patients and convenient in-store pickup at each of its 87 dispensaries in Florida.
To assist patients with ordering, Trulieve’s entire catalog of products is available for online orders, with in-store pickup or statewide home delivery options available depending on patient preference. Additionally, Trulieve offers complimentary 30-minute virtual consultations with a Trulieve consultant to help navigate questions on products, devices, or review their doctor’s recommendation. Appointments can be made on Trulieve’s website and are open to all patients, whether starting their journey with medical cannabis or those with experience looking for alternative treatment options.
Trulieve continues to monitor the COVID-19 situation and to ensure the highest level of safety of our patients and staff. Per current CDC guidelines, we continue to encourage social distancing, the use of plexiglass shields and all employees continue to wear masks. We encourage unvaccinated patients to also adhere to CDC guidelines and wear a mask in our stores.
For more information, please visit www.Trulieve.com.
Trulieve is primarily a vertically integrated “seed-to-sale” company in the U.S. and is the first and largest fully licensed medical cannabis company in the State of Florida. Trulieve cultivates and produces all of its products in-house and distributes those products to Trulieve-branded stores (dispensaries) throughout the State of Florida, as well as directly to patients via home delivery. Trulieve also holds licenses to operate in California, Massachusetts, Pennsylvania, Connecticut, and West Virginia. Trulieve is listed on the Canadian Securities Exchange under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF.
To learn more about Trulieve, visit www.Trulieve.com.
SOURCE Trulieve Cannabis Corp.
This is not a CAPTIS article. Originally, it was published here.